A better understanding of the pathogenesis of bone erosion in RA relates to the discovery of osteoclast-mediated bone resorption that is regulated by the receptor activator of nuclear factor-κB (RANK) ligand (RANKL) [2-5,11,12]. The gene discussed is TNFRSF11A; the disease is rheumatoid arthritis.